热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
APC anti-human CD274 (B7-H1, PD-L1) Antibody
产品名称：
APC anti-human CD274 (B7-H1, PD-L1) Antibody
产品类别：
抗体
产品编号：
329707
产品应用：
329707
[价格]
规格 价格 库存
25tests ￥ 1656 1

产品详情

Product Details

Verified Reactivity
Human
Reported Reactivity
African Green, Baboon, Cynomolgus, Rhesus
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Full length human PD-L1
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 29E.2A3 is reported to recognize an epitope on PD-L1 within the PD-L1-CD80 binding region5.?Additional reported applications (for the relevant formats) include: blocking1-3 and immunohistochemical staining of acetone-fixed frozen sections1.?The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 329715, 329716, 329745 - 329748).?

It has been observed that clone 29E.2A3 is able to bind to Alexa Fluor? 700 antibody conjugates during multi-color immunofluorescent staining. This interaction can be resolved by sequentially staining with the 29E.2A3 antibody first and then followed by the?Alexa Fluor? 700?conjugate of interest.

Clone 29E.2A3 does not work in Western blot applications7.

Application References

(PubMed link indicates BioLegend citation)
  1. Brown J, et al. 2003. J. Immunol. 170:1257. (FC, IHC, Block)
  2. Radziewicz H, et al. 2007. J. Virol. 81:2545. (Block)
  3. Nakamoto N, et al. 2009. PLoS Pathog. 5:e1000313. (Block)
  4. Barsoum IB, et al. 2014. Cancer Res. 74:665. PubMed
  5. Haile, S et al. 2013. J. Immunol. 191:2829.
  6. RL M, et al. 2015. PNAS. 112:6506-6514. PubMed
  7. Mahoney KM, et al. 2015. Cancer Immunol. Res. 3:1308.
Product Citations
  1. Kuryk L, et al. 2019. Oncoimmunology. 8:e1532763. PubMed
  2. Saha D et al. 2017. Cancer cell. 32(2):253-267 . PubMed
  3. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  4. Oreskovic E, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  5. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  6. Sapski S, et al. 2020. Cancer Immunol Immunother. 2291:69. PubMed
  7. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  8. Rauch DA, et al. 2019. Blood. 134:1406. PubMed
  9. Sun X, et al. 2020. Am J Cancer Res. 10:564. PubMed
  10. Fu Y, et al. 2020. Sci Rep. 10:9027. PubMed
  11. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  12. Tanaka C, et al. 2021. Molecules. 26:. PubMed
  13. Hakroush S, et al. 2021. Front Immunol. 11:624547. PubMed
  14. Cen B, et al. 2021. Oncogene. 40:5984. PubMed
  15. Leite NC, et al. 2020. Cell Reports. 32(2):107894.. PubMed
  16. Cui J, et al. 2020. Cancers (Basel). 0.596527778. PubMed
  17. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  18. Jiang X, et al. 2013. Clin Cancer Res. 19:598. PubMed
  19. Ng W, et al. 2021. Pharm Biol. 59:47:00. PubMed
  20. Chou CW, et al. 2020. Am J Cancer Res. 2621:10. PubMed
  21. Li C, et al. 2021. J Immunother Cancer. 9:. PubMed
  22. Shevyrev D, et al. 2021. Exp Ther Med. 209:21. PubMed
  23. Toews K, et al. 2020. Mol Carcinog. 724:59. PubMed
  24. Hsu H, et al. 2016. J Immunol. 197: 1884 - 1892. PubMed
  25. Bernareggi D, et al. 2022. Nat Commun. 13:1899. PubMed
  26. Baleeiro RB, et al. 2022. Oncoimmunology. 11:2080329. PubMed
  27. Chen LM, et al. 2021. Biosci Rep. 41:. PubMed
  28. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  29. Johnson D, et al. 2016. Nat Commun. 7:10582. PubMed
  30. Izmirly AM, et al. 2022. PLoS Pathog. 18:e1009903. PubMed
  31. Taniguchi H, et al. 2022. Cell Rep. 39:110814. PubMed
  32. Xi X, et al. 2021. Oncol Lett. 22:716. PubMed
  33. Kotetsu Y, et al. 2021. Biomedicines. 9:. PubMed
  34. Miranda A, et al. 2015. Cancer Res . 75: 3032-3042. PubMed
  35. Atefi M, et al. 2014. Clin Cancer Res. 20:3446. PubMed
  36. Wallstabe L et al. 2019. JCI Insight. 4(18) pii: 126345. PubMed
  37. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  38. Arlt A, et al. 2020. Mol Oncol. 14:571. PubMed
  39. Huang BR, et al. 2020. Int J Mol Sci. 21:00. PubMed
  40. Yang WH, et al. 2018. Cancer Res. 78:3761. PubMed
  41. Chen LM, et al. 2021. Biosci Rep. Online ahead of print. PubMed
  42. Fu H, et al. 2021. Front Cell Dev Biol. 9:764109. PubMed
  43. Yoshida R, et al. 2022. Cancer Res. :. PubMed
  44. Koopmans I, et al. 2018. Oncoimmunology. 7:e1466016. PubMed
  45. Lim KH, et al. 2020. Nat Commun. 2.889583333. PubMed
  46. Capuano C, et al. 2018. Front Immunol. 9:1031. PubMed
  47. Wertel I, et al. 2020. J Immunol Res. 1715064:2020. PubMed
  48. Zhao L, et al. 2018. Oncol Lett. 16:1180. PubMed
  49. Jiao S, et al. 2017. Clin Cancer Res. 23:3711. PubMed
  50. Palakurthi S, et al. 2019. Cancer Immunol Res. 1.303472222. PubMed
  51. Saraiva DP, et al. 2018. Front Immunol. 2.184027778. PubMed
  52. Volpin V, et al. 2020. Cancer Immunol Res. 8:1163. PubMed
  53. Li Z, et al. 2020. Front Cell Dev Biol. 8:572689. PubMed
  54. Lin G, et al. 2021. Mol Med Rep. 23:. PubMed
  55. Ofori S, et al. 2019. ACS Omega. 4:12584. PubMed
  56. Sam J, et al. 2020. Front Oncol. 10:575737. PubMed
  57. Jin MH, et al. 2019. Cancer Res Treat. N/A. PubMed
  58. Renner K, et al. 2020. Cell Reports. 29(1):135-150.e9.. PubMed
  59. Mackroth M, et al. 2016. PLoS Pathog. 12:e1005909. PubMed
  60. Jiang L, et al. 2019. Sci Rep. 9:3705. PubMed
  61. Wang B, et al. 2018. Mol Ther Nucleic Acids. 0.548611111. PubMed
  62. Gorris MAJ, et al. 2018. J Immunol. 200:347. PubMed
  63. Wang X, et al. 2022. J Exp Clin Cancer Res. 41:210. PubMed
  64. Tameishi M, et al. 2021. Pharmaceuticals (Basel). 14:. PubMed
  65. Liu YS, et al. 2021. Cancers (Basel). 13:. PubMed
  66. O'Connor MH, et al. 2021. Commun Biol. 4:563. PubMed
  67. Luna-Yolba R, et al. 2021. Cancers (Basel). 13: . PubMed
  68. Zheng Y, et al. 2022. Transl Res. :. PubMed
  69. Parent AV, et al. 2021. Cell Reports. 36(7):109538. PubMed
  70. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  71. Hassounah NB, et al. 2019. Cancer Immunol Immunother. 68:407. PubMed
  72. Pawlicki JM, et al. 2021. Cancer Res. 81:3241. PubMed
RRID
AB_940358 (BioLegend Cat. No. 329707) AB_940360 (BioLegend Cat. No. 329708)

Antigen Details

Distribution

T cells, B cells, NK cells, monocytes/macrophages, granulocytes and dendritic cells

Function
CD274 is involved in the costimulatory signal, essential for T lymphocyte proliferation and production of IL-10 and IFN-γ, in an IL-2-dependent and a PD-1-CD1-independent manner. Its interaction with PD-1-CD1 inhibits T-cell proliferation and cytokine production.
Ligand/Receptor
PD-1 (PDCD1)
Cell Type
B cells, Dendritic cells, Fibroblasts, Granulocytes, Macrophages, Monocytes, NK cells, T cells
Biology Area
Cancer Biomarkers, Costimulatory Molecules, Immunology
Molecular Family
Adhesion Molecules, CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Sharpe A, et al. 2007. Nat. Immunol. 8:239.

Gene ID
29126 View all products for this Gene ID
UniProt
View information about CD274 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线